231 related articles for article (PubMed ID: 3510083)
1. Prevention of coronary heart disease--propaganda, promises, problems, and prospects.
Oliver MF
Circulation; 1986 Jan; 73(1):1-9. PubMed ID: 3510083
[No Abstract] [Full Text] [Related]
2. Strategy, yield and risks of controlling plasma lipids in the primary prevention of coronary heart disease.
Oliver MF
Adv Exp Med Biol; 1985; 183():225-40. PubMed ID: 3898747
[No Abstract] [Full Text] [Related]
3. [Is hypolipemic treatment effective as a preventive measure?].
Rywik S
Przegl Lek; 1989; 46(7):619-23. PubMed ID: 2685917
[No Abstract] [Full Text] [Related]
4. Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial.
Carlson LA; Olsson AG
Lancet; 1979 Apr; 1(8121):869-70. PubMed ID: 86108
[No Abstract] [Full Text] [Related]
5. Sounding Board. Diet and coronary heart disease: another view.
Glueck CJ; Mattson F; Bierman EL
N Engl J Med; 1978 Jun; 298(26):1471-3. PubMed ID: 206833
[No Abstract] [Full Text] [Related]
6. Does hypolipidemic therapy prevent coronary heart disease?
Rifkind BM; Levy RI
Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
[No Abstract] [Full Text] [Related]
7. Diet-Heart: end of an era.
Mann GV
N Engl J Med; 1977 Sep; 297(12):644-50. PubMed ID: 197407
[No Abstract] [Full Text] [Related]
8. Can modification of risk factors reduce coronary heart disease?
Grundy SM
Cardiovasc Clin; 1983; 13(1):283-96. PubMed ID: 6336670
[No Abstract] [Full Text] [Related]
9. General therapeutic and prophylactic problems in the treatment of atherosclerosis.
Begg TB
Acta Cardiol; 1972; ():Suppl 15:101-1. PubMed ID: 4583031
[No Abstract] [Full Text] [Related]
10. [Real or alleged risks of clofibrate derivatives and certain risks of their prohibition].
de Gennes JL
Nouv Presse Med; 1979 Mar; 8(15):1223-5. PubMed ID: 375186
[No Abstract] [Full Text] [Related]
11. A long-time study of the blood lipids of two students of atherosclerosis.
Page IH; Lewis LA
Circulation; 1969 Dec; 40(6):915-8. PubMed ID: 5387364
[No Abstract] [Full Text] [Related]
12. [Preventing arteriosclerotic coronary disease by changing the diet and mode of life].
Stamler J; Mojonnier L; Hall Y; Berkson D; Lindberg H
Kardiologiia; 1971 May; 11(5):26-39. PubMed ID: 5126315
[No Abstract] [Full Text] [Related]
13. Strategy of prevention: lessons from cardiovascular disease.
Rose G
Br Med J (Clin Res Ed); 1981 Jun; 282(6279):1847-51. PubMed ID: 6786649
[No Abstract] [Full Text] [Related]
14. [Prevention of cardiovascular diseases].
Akhmeteli MA
Kardiologiia; 1982 May; 22(5):47-54. PubMed ID: 7047855
[No Abstract] [Full Text] [Related]
15. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
Br Heart J; 1978 Oct; 40(10):1069-118. PubMed ID: 361054
[No Abstract] [Full Text] [Related]
16. [The etiology, pathogenesis and prevention of coronary heart disease].
Gloutsal L; Dushek Ia
Kardiologiia; 1971; 11(12):31-40. PubMed ID: 5147883
[No Abstract] [Full Text] [Related]
17. The clofibrate trial--the lipid hypothesis retested.
Med J Aust; 1979 Jun; 1(11):490-1. PubMed ID: 381862
[No Abstract] [Full Text] [Related]
18. Clofibrate: a final verdict?
Lancet; 1978 Nov; 2(8100):1131-2. PubMed ID: 82687
[No Abstract] [Full Text] [Related]
19. Hypertension, blood lipids, and cigarette smoking as co-risk factors for coronary heart disease.
Kannel WB
Ann N Y Acad Sci; 1978 Mar; 304():128-39. PubMed ID: 212996
[No Abstract] [Full Text] [Related]
20. Cholesterol, coronaries, clofibrate and death.
Oliver MF
N Engl J Med; 1978 Dec; 299(24):1360-2. PubMed ID: 362204
[No Abstract] [Full Text] [Related]
[Next] [New Search]
